In the closing of the recent trading day, Moderna (MRNA) stood at $27.54, denoting a +2.53% move from the preceding…
In the most recent trading session, Moderna (MRNA) closed at $25.90, indicating a +1.97% shift from the previous trading day.…
…
Modernas shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the…
Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects…
US FDA approves expanded use of Moderna’s RSV vaccine for at-risk adults…
…
An den US-Börsen ist in den ersten Handelsstunden nur wenig Bewegung zu beobachten. Der Leitindex Dow Jones notiert gut zwei…
An den US-Börsen ist in den ersten Handelsstunden nur wenig Bewegung zu beobachten. Der Leitindex Dow Jones notiert gut zwei…
Nächster Paukenschlag in den USA: Gesundheitsminister Robert F. Kennedy Jr. hat alle Mitglieder eines Gremiums (ACIP) von Impfexperten der US-…
Moderna, Pfizer, and BioNTech stocks dip on vaccine panel overhaul…
…
Moderna agrees to true placebo-controlled trial of new COVID vaccine, Kennedy says…
FDA grants limited approval to Moderna’s new mRNA COVID vaccine…
…
These are the stocks posting the largest moves in the premarket.…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares edged higher after the US Food and Drug Administration (FDA) approved its newest COVID-19 vaccine…
The U.S. approved a new Covid-19 vaccine made by Moderna but with limits on who can use it — not…
…
Moderna at Bernstein Conference: Strategic Diversification Plans…
The Trump administration canceled $766 million awarded to Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including…
The government scraps funding deal for MRNAs bird flu shot, despite encouraging safety and efficacy data from early clinical studies…
Bad Marienberg (www.aktiencheck.de) - Die jüngste Entscheidung der US-Regierung, einen Vertrag über insgesamt 766 Millionen USD mit Moderna Inc. (ISIN:…
US cancels more $700 million funding for Moderna bird flu vaccine…
The Trump administration has cancelled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for…
Moderna files with FDA for updated Spikevax aimed at the LP.8.1 variant, which makes up 70% of U.S. COVID-19 cases.…
Moderna files application for updated COVID vaccine…
Moderna said on Friday it had filed a marketing application for an updated COVID vaccine to the U.S. Food and…
Modernas voluntary withdrawal of the filing stems from the FDAs request for vaccine efficacy data from a phase III study…
Though the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer and…
These are some of the stocks posting the largest moves in midday trading.…
…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares jumped more than 6.5% on Tuesday after the US Food and Drug Administration unveiled a…
Modern commerce still runs on the most volatile of fuels: human motivation.…
Moderna plans to launch 10 new marketed products over the next three years, aiming to diversify a revenue base, which…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) could face a longer-term threat from a newly announced US government initiative to develop universal vaccines…
The headline numbers for Moderna (MRNA) give insight into how the company performed in the quarter ended March 2025, but…
…
MRNA reports mixed Q1 results. The company reiterates 2025 sales guidance but announces a cost-cutting initiative to reduce expenses significantly…
Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the companys cost-cutting efforts following…
London (www.aktiencheck.de) - Moderna-Aktienanalyse von HSBC:
Aktuelle Bewertung
HSBC hat das Kursziel für Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol:…
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Sanford C. Bernstein & Co:
1. Hintergrund
Bernstein hat das Kursziel für die Aktie von Moderna…
…
In many ways, the pandemic is becoming a faded memory. With that, a major pandemic star -- biotech Moderna (NASDAQ:…
What should investors do during a stock-market correction? One great strategy is to go shopping. A bull market will eventually…
The latest trading day saw Moderna (MRNA) settling at $27.19, representing a -0.75% change from its previous close.…
Moderna (MRNA) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…
In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and…
Moderna erreicht neues Jahres-Tief bei 21,67 Euro. Analysten halten sich mit Empfehlungen zurück, während wichtige Termine bevorstehen. Die Moderna-Aktie zeigt…
Moderna (MRNA) reachead $24.73 at the closing of the latest trading day, reflecting a -1.85% change compared to its last…